B&B PHARMA
0554.988.666 · rovalta.com · 25/09/2026
B&B PHARMA
Financial year 2024 · Closed on 31/12/2024
Overview
Identity
Source · BCE/KBOB&B PHARMA is a Private limited company incorporated in 2014. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Beersel.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0554.988.666
- Incorporation
- 02/07/2014
- Legal form
- Private limited company
- Registered office
- Blarenveld 18
1650 Beersel · FlandreSee on map - Contributed capital
- 18 600,00 €
- Latest accounts
- 31/12/2024
Financials
Source · NBB, 11 filingsTrend over 10 financial years
| 2024 | 2023 | 2022 | 2021 | 2020 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 138,4 k € | -62.0% | 364,2 k € | +54.0% | 236,6 k € | +43.9% | 164,4 k € | +73.2% | 94,9 k € |
| EBITDA | 138,2 k € | -62.0% | 363,3 k € | +53.6% | 236,5 k € | +45.4% | 162,7 k € | +72.0% | 94,6 k € |
| Operating result | 123,4 k € | -64.6% | 348,2 k € | +57.6% | 220,9 k € | +49.6% | 147,7 k € | +82.8% | 80,8 k € |
| Net result | 30,2 k € | -91.2% | 341,5 k € | +102% | 169,4 k € | -25.0% | 225,7 k € | +77.4% | 127,2 k € |
| Balance sheet | |||||||||
| Equity | 212,2 k € | -44.4% | 382 k € | +843% | 40,5 k € | -72.8% | 149,1 k € | +0.2% | 148,9 k € |
| Total assets | 860,9 k € | -4.5% | 901,9 k € | +4.4% | 864,1 k € | -2.0% | 881,6 k € | -1.0% | 890,4 k € |
| Cash | 10,3 k € | +46.1% | 7 k € | -53.5% | 15,1 k € | -34.5% | 23,1 k € | +1604% | 1,4 k € |
| Debts | 641,2 k € | +23.3% | 519,9 k € | -36.9% | 823,5 k € | +12.4% | 732,4 k € | -1.2% | 741,5 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20242 active · 3 ended
Active mandates
Ended mandates
Financials
Full financial information
Source · NBB| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Micro model |
| Start of the financial year | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 |
| Closing of the financial year | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 19/08/2025 | 29/08/2024 | 06/08/2023 | 13/07/2022 | 02/07/2021 | 07/07/2020 |
| General meeting | 23/07/2025 | 31/07/2024 | 30/06/2023 | 08/06/2022 | 09/06/2021 | 10/06/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 11 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2024 | 23/07/2025 | 19/08/2025 | French | |
| Abridged model | 31/12/2023 | 31/07/2024 | 29/08/2024 | French | |
| Abridged model | 31/12/2022 | 30/06/2023 | 06/08/2023 | Dutch | |
| Abridged model | 31/12/2021 | 08/06/2022 | 13/07/2022 | Dutch | |
| Abridged model | 31/12/2020 | 09/06/2021 | 02/07/2021 | French | |
| Micro model | 31/12/2019 | 10/06/2020 | 07/07/2020 | French | |
| Abridged model | 31/12/2018 | 12/06/2019 | 28/08/2019 | French | |
| Abridged model | 31/12/2017 | 13/06/2018 | 31/07/2018 | French | |
| Abridged model | 31/12/2016 | 14/06/2017 | 30/08/2017 | French | |
| Abridged modelCorrection | 31/12/2015 | 22/09/2016 | 23/09/2016 | French | |
| Abridged model | 31/12/2015 | 12/05/2016 | 13/05/2016 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 500 k€ and 1 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20242 active · 3 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Other11/12/2025STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
- Mandates23/04/2024ONTSLAGEN - BENOEMINGEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM
- Registered office14/05/2018MAATSCHAPPELIJKE ZETEL
- Registered office03/03/2016SIEGE SOCIAL
- Mandates03/03/2015DEMISSIONS, NOMINATIONS
- Other04/07/2014RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2024Annual accounts 202430,2 k €↓
- 2023Annual accounts 2023341,5 k €↑
- 2023Name changeBB PHARMA
- 2022Annual accounts 2022169,4 k €↓
- 2021Annual accounts 2021225,7 k €↑
- 2021Name changeB&B PHARMA
- 2020Annual accounts 2020127,2 k €↑
- 2019Annual accounts 201950,9 k €↑
- 2018Annual accounts 2018-61,6 k €↓
- 2017Annual accounts 201761,8 k €↑
- 2016Annual accounts 201629,3 k €↓
- 2015Annual accounts 201556,3 k €
- 02/07/2014IncorporationPrivate limited company